Debt-equity comparisons considering WACC, corporate tax, leverage, cost of debt

The book I am using is Fundamental of Corporate Finance, 4e a) Why is debt a comparatively cheaper form of finance than equity? b) If debt is cheaper than equity, why do companies approach the equity markets? c) How can one minimize WACC when there is a constraint on raising debt? if so, how? d) What are the effects of a corporate tax on the WACC of a business? e) Is minimizing WACC by having a largely debt-based capital structure a high-risk strategy, given the threat of bankruptcy in an overleveraged business? Explain your answer. f) What are the extraneous factors which impact the ability of a business to radically alter its debt-equity mix?

Decision Analysis 11428

I need solution to a decision analysis problem (below and in attachment) --- Bill Goodman has been offered the opportunity to invest $15,000 in a start-up company that intends to supply personal digital assistants (PDAs) to physicians in order to enable them to determine the approved medication for each HMO patient they treat. The business plan for this start-up calls for raising a total of between $10 million and $40 million in financing and then taking the company public. To be successful in raising these funds, the firm must first be able to hire a respected professional in the medical industry to be the firm's CEO. Bill believes that there is a 80% chance of the firm accomplish... click for more

What is the best developed procedure for doing market wage surveys?

I am seeking some information on a best approach to perform a salary survey on a group of employees working for a county. A methodologic approach is what is needed.

A company exports goods to France and Sweden...

Please see the attachment for problems. --- A company exports goods to France and Sweden. These markets exhibit different demand schedules and price elasticities... ---

Research Discussion

Sometimes, research with new pharmaceutical products may be risky to human subjects. It's big business - look what Viagra did for Pfizer stock. And, as patents expire, companies need new designer drugs to maintain profit margins. What tradeoffs do you see between full disclosure of all research risks and preventing potential subject bias? What other ethical considerations can you identify when working with human subjects?